Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Richard Baker

Optometrist Houston, TX Doctor of Optometry

NPI 1750345658 CMS profile 698243

3900 Essex Ln, Suite 101, Houston, TX 77027

Open in the dashboard

General payments

$78,098

50 records reported · program years 2019–2025

Research payments

$22

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$164,773

3 holdings reported · through program year 2025

Through program year 2025, Richard Baker of Houston, TX is reported in the CMS Open Payments database as having received $78,098 across 50 general payments and $22 in research payments paid to them. They also declared ownership or investment interests valued at $164,773 across 3 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $20 1
2024 General $74,859 8
2022 General $136 7
2021 General $374 17
2021 Research $22 2
2020 General $2,300 2
2019 General $409 15
2022 Ownership $61,323 1
2021 Ownership $54,450 1
2020 Ownership $49,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Richard Baker
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Richard Baker were reported at $20. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Richard Baker Optometrist median Middle half National median
2019 $409 $159 $67–$371 $163
2020 $2,300 $72 $29–$165 $114
2021 $374 $125 $46–$292 $132
2022 $136 $162 $66–$374 $149
2023 $0 $177 $72–$406 $160
2024 $74,859 $188 $77–$427 $164
2025 $20 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. RxSight Inc $76,923 4 payments
  2. TissueTech, Inc. $236 6 payments
  3. Alcon Vision LLC $174 7 payments
  4. Bausch & Lomb, a division of Bausch Health US, LLC $123 6 payments
  5. CooperVision Inc. $99 1 payment
  6. Sun Pharmaceutical Industries Inc. $89 4 payments
  7. Allergan Inc. $82 4 payments
  8. Novartis Pharmaceuticals Corporation $81 5 payments
  9. Johnson & Johnson Surgical Vision, Inc. $73 3 payments
  10. AbbVie, Inc. $65 3 payments
  11. Other $153 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $74,606 1 payment
  2. Consulting Fee $2,300 2 payments
  3. Food and Beverage $1,192 47 payments
Products named General payments · program years 2019–2025
  1. RXSIGHT CONTACT LENS $74,606 1 payment
  2. RXSIGHT INJECTOR CARTRIDGE $74,606 1 payment
  3. RXSIGHT INJECTOR HANDPIECE $74,606 1 payment
  4. RXSIGHT LIGHT DELIVERY DEVICE (LDD) $74,606 1 payment
  5. LIGHT ADJUSTABLE LENS (LAL) $74,606 1 payment
  6. LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) $2,317 3 payments
  7. Prokera $189 4 payments
  8. AmnioGraft $189 4 payments
  9. AmnioGuard $189 4 payments
  10. VUITY $122 6 payments
  11. Other $972 41 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. RxSight Inc $22 2 payments

Records

52 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record